INTRODUCTION
============

SV40 T antigen is a well-known oncogene, and tumor cell would emerged in different kinds mice model of SV40 T antigen transgenic mice [@B1]-[@B4]. SV40 T antigen (T antigen) under the control of the rat insulin gene promoter region is used to produce Rip1-Tag2 mice, which is overt pancreatic β-cell tumor model [@B5]. This mice model is used to study tumor development and tumor angiogenesis. Even pancreatic tumor pathology of those model mice was standardized nomenclature with definitions [@B6], [@B7]. Generally the Rip1-Tag2 mice is not regard as metastasis animal model, however, we unexpectedly observed the micrometastasis in Rip1-Tag2 mice in tumor advanced stage that is not reported before. It is of great significance for studying the process of metastasis of cancer cell or the characteristics of metastasis cell.

As well known, in Rip1-Tag2 transgenic mice, T antigen and insulin are linked together in gene location and expression simultaneously cue to under the same promoter. T antigen inactivate of the Rb protein and P53 [@B8]-[@B14], targeting multiple cell function including regulate cell proliferation, death, immune responses and even the tumor microenvironment involved in that process [@B15]-[@B17]. With tumor development, T-antigen expression level is down-regulated as previous reports had said [@B18]. Although the tumorigenesis process is triggered by Tag, it remains unknown whether continuous T antigen expression is necessary for growth or metastasis cell in Rip1-Tag2 mice.

In this study, our results demonstrated that micrometastasis express insulin and T antigen, but their expression in primary tumor was down-regulated in advanced stage in Rip1-Tag2 mice. The contribution of this study is that micrometastasis character in Rip1-tag2 mice, expressing T antigen and insulin, was established. Interestingly and importantly, the findings suggested that micrometastasis return back to undifferentiated state like cancer stem cell expressing insulin again. In addition, insulin-producing cells is important for diabetic patients [@B19], [@B20].

MATERIALS AND METHODS
=====================

Transgenic mice
---------------

The Rip1-Tag2 (C57BL/6 mice as background mice) mice were purchased from The Jackson Laboratory, and C57/BL6 mice were obtained from Animal Center of Guangdong province (Guangzhou, China). The advanced stage of mice refers to about 14 weeks of Rip-Tag2 mice. The studies of transgenic mice and C57BL/6 mice were reviewed and approved by the Committees for Ethical Review of Research involving Animal Subjects at Guangdong Pharmaceutical University, China.

HE staining
-----------

Mice pancreases and other tissues were fixed overnight in 4% formalin. Fixed tissues were rinsed in 1×PBS, subsequently dehydrated in 35, 50, and 75% ethanol, then embedded in paraffin. 10 μm sections were deparrafinized in xylene and rehydrated in 100, 95, 70, and 50% ethanol then 1×PBS. H&E staining of sections was carried out as previously described [@B21].

Immunohistochemistry
--------------------

Immunohistochemistry (IHC) was performed as described on the web of Cell Signaling Technology, Inc (MA, USA), Primary antibody include T-antigen (1:100, Abcam), C-petide antibody (1:100, Abcam), and Insulin antibody (1:200, Fitzgerald), and second antibody system was purchased from Genetech (Shanghai, China). The slides for T-antigen and C-petide antibodies were treated with EDTA solution (pH=9.0) for antigen retrieval, while the slides corresponding insulin antibody was no treated for antigen retrieval.

Statistical Analysis
--------------------

SPSS 16.0 (SPSS Inc., Chicago, USA) was adopted to analyze our data. The IHC results of C57BL/6 and Rip1-Tag2 mice were compared using Pearson\'s Chi-square test. A *P* value less than 0.05 was considered statistically significant.

RESULTS
=======

Identification of Rip1-Tag2 transgenic mice
-------------------------------------------

To obtain the Rip-Tag2 transgenic mice, we identified the transgenic mice by detecting T antigen with PCR, which located downstream of mouse insulin promoter (Fig.[1](#F1){ref-type="fig"}A). Primer sequences used are shown: the forwards primer: 5\'-GGACAAACCACAACTAGAATGCAG-3\' and reverse primer: 5\'-CAGAGCAGAATTGTGGAGTGG-3\'. PCR conditions were showed as: 94℃ 2min; 94℃ 30sec, 56℃ 30s, 72℃ 30s (35 cycles); 72℃10min. PCR product size is about 500bp. Rip1-Tag2 transgenic mice were shown as lane 1, 3 and lane 6 (shown in Fig.[1](#F1){ref-type="fig"}B).

Pathological Progress of islet β cell tumor in Rip1-Tag2
--------------------------------------------------------

β cells of Rip1-Tag2 transgenic mice secrete insulin, and SV40 T antigen (T antigen) under insulin promoter express simultaneously. β cells developed a multi-stage pancreatic tumor (As shown in Fig.[2](#F2){ref-type="fig"}), about 1-3 weeks, it was known as "Normal stage", in which Islet cell had no difference with C57BL/6 mice (Fig [1](#F1){ref-type="fig"}A); At 4-5weeks of age, hyperplastic islet/dysplastic began to appear, most of cell nuclear/cytoplasm ratio increases, but the vascular system remained quiescent at this stage (Fig [2](#F2){ref-type="fig"}B). From about 6 weeks, it began to appear angiogenic Islets and different sizes of angiogenic Islets were formed, We could see the nuclear/plasma ratio remained increasing, and the vascular system was activated as well as branch multiplied (Fig [2](#F2){ref-type="fig"}C). In 9-10 weeks tumor appeared, nuclear/cytoplasm ratio and cell density reached the highest, and the vascular network was densely developed (Fig [2](#F2){ref-type="fig"}D), In the advanced stage about 14 weeks (Fig [2](#F2){ref-type="fig"}E and [2](#F2){ref-type="fig"}F), about half of the tumors infiltrated into the surrounding acinar tissue.

Micrometastasis arise in lung and spleen expressing insulin and T antigen
-------------------------------------------------------------------------

Metastasis was few reported in Rip1-Tag2 mice. To validate if the micrometastasis had existed in multiple organ systems in advanced stage referring to 14 weeks of β cell tumor, we performed IHC to detect lung and spleen tissue with insulin, C-peptide, and T-antigen antibody. Insulin was known as a peptide hormone produced only by β cells, and C-peptide is a peptide composed of 31 amino acids which is released from the pancreatic beta-cells. T-antigen antibody, which gene was located link together with insulin gene in this transgenic mice as shown in Fig.[1](#F1){ref-type="fig"}. By comparing the two results of Rip1-Tag2 mice and background wild type C57BL/6 mice, we found that the insulin expression positive cells were arising obviously in the lung and spleen, as shown in Fig. [3](#F3){ref-type="fig"}A. Further C-peptide and T-antigen expressing cell also were detected in lung and spleen of Rip1-Tag2 mice (Fig [3](#F3){ref-type="fig"}B and [3](#F3){ref-type="fig"}C), the results showed C-peptide and T-antigen all present in micrometastasis of lung and spleen. In addition, most micrometastassis size is less than 10 tumor cells. We further counted the number of micrometastasis in lung and spleen of Rip1-Tag2 mice in five consecutive sides not repeating count the same micrometastasis, not finding the micrometastasis in C57BL/6 mice. The number of micrometastsis were significantly statistical differences in lung and spleen comparing with the corresponding to mice, as shown in Fig. [3](#F3){ref-type="fig"}D, \*P\<0.0001.

Pathological structure of lung and spleen in advanced stage were damaged
------------------------------------------------------------------------

To clarity if micrometastasis of β cell tumor had damaged and affected architecture of lung and spleen in Rip1-Tag2 mice, HE staining was used to detect the pathological structure of lung, and spleen. As shown in Fig.[4](#F4){ref-type="fig"}A, RIP1-Tag2 mice\'s lung and spleen were damaged obviously, Reactive hyperplasia of lymphoid tissue were seen in spleen, and thickened and bleeding of the alveolar septa, congestion of capillary, hemorrhagic foci were visible in lung, all the features as shown in Fig [4](#F4){ref-type="fig"}A. But the pathological structure of lung and spleen of C57BL/6 mice was no altering (Fig. [4](#F4){ref-type="fig"}B).

Insulin and T antigen highly express in hyperplasia islet but down-regulation in invasive carcinoma
---------------------------------------------------------------------------------------------------

Early reported indicated the protein expression of T antigen would decrease with the development of tumor, in our study, to further confirm that the insulin and T antigen expression are decrease with the development of primary tumor, we detected the Insulin and T antigen expression in hyperplastic islet (4 weeks) and invasive carcinoma (about 14 week) by performing IHC. The results demonstrated that Insulin expression was obviously down-regulation in invasive carcinoma than in hyperplastic islet, as shown in Fig. [5](#F5){ref-type="fig"}, P\<0.01. The results indicated that tumor cells highly expressed insulin in hyperplasia, while the level of insulin and T antigen decrease in invasive carcinoma.

Above data clue us that the micrometastasis cell maybe derived from hyperplasia at early tumor stage remain quiescent state. Alternatively, micrometastasis return undifferentiated cell state from invasive carcinoma.

DISCUSSION
==========

Rip1-Tag2 mice have been used as pancreatic islet β cell tumor model for studying angiogenesis, cancer development and autoimmunity etc. In many reports, with the growth of transgenic mice, islet β cell tumor begin to happen in transgenic mice [@B4], [@B22] and the pathologic structure of pancreas will alter with mice age. There is a trend toward loss islet morphological structure in advanced stage of tumor. And we also confirmed that the pancreatic islets undergo from incipient neoplasia to advanced stage of tumors. T antigen was regarded as manipulating under insulin promoter which is essential for both the initiation of the tumor transformed state [@B22]-[@B25].

In this transgenic mice model, Insulin is linked together T-antigen in gene location under control insulin promoter, and we confirmed that T antigen and insulin both are down-regulated in invasive carcinoma stage by IHC analysis, which is consistent with previous reports [@B26], [@B27]. Generally speaking, the micrometastasis may happen in multiple tissue in advanced stage of tumor patients, and we also observed a few of micrometastasis in spleen, and lung in transgenic mice, this results maybe is analogous to thing that we see in tumor patient. Lung and spleen structure damage demonstrates that it may produce subtle influence on organ structure and their function with the developing of tumor and micrometastasis. Micrometastasis tumor cell has potent effects on lung and spleen in advanced stage (14 weeks), which may result in chronically cancer microenvironment and structure change.

Interestingly, the other team study informed us that these metastasis cells was supposed as tumor-initiating cells or cancer stem cell can originate from proliferating undifferentiated precursor cells. In this study, micrometastasis expressed insulin but the tumor cell in invasive carcinoma barely express insulin, which potently revealed those micrometasis cancer cell remains precursor cell feature, suggesting that micrometastasis remain undifferentiated cell state in non cancer cells population and microenvironment.

In summary, the results demonstrated the micrometastasis cell may be derived from pancreatic islet expressing insulin at early stage, because in invasive carcinoma stage its expression is down-regulated, lastly affecting on the organs tissue structure. Alternatively, micrometastasis left at invasive carcinoma stage, then go back an undifferentiated cell state to secrete insulin. micrometastasis have cancer stem cell feature similar to the original pancreatic β cell. Of course, further study is still needed to explore these metastatic sporadic tumor cell.
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![**Identification of the gene-type of Rip1-Tag2 mice.**T-antigen gene was identified by using PCR assay. The lanes 2, 4, 5 indicated Tag2 were negative (-), but the lanes 3, and 6 show Tag2 were positive (+). Lane 1 was regard as positive control. M was indicated the Marker DL2000.](ijbsv10p0136g001){#F1}

![**The process of Pancreatic βcell tumor in Rip1-Tag2 transgenic mice.**A. Normal stage, the Islet cell is normal and same as C57BL/6 mice(Fig [2](#F2){ref-type="fig"}A); B. Hyperplastic islet stage, dysplastic begin to appear, most of cell nuclear/cytoplasm ratio increases(Fig [2](#F2){ref-type="fig"}B), C. Angiogenic islets stage, angiogenic Islets began to appear(Fig [2](#F2){ref-type="fig"}C), D. Tumor stage, the vascular network is highly developed, solid tumors formed(Fig [3](#F3){ref-type="fig"}D). E. Invasion stage. Tumor infiltrate into the surrounding acinar tissue (Fig [2](#F2){ref-type="fig"}E and [2](#F2){ref-type="fig"}F).](ijbsv10p0136g002){#F2}

![**Micrometastasis appears in lung and spleen in Rip1-Tag2 mice.**A. Micrometastasis size was defined as no more than 10 cells per section (10μm). Micrometastasis tumor cell expressing insulin rise in lung and spleen as shown in Fig.[3](#F3){ref-type="fig"}A (magnification: 600×). B. Micrometastasis was further confirmed by IHC assay, C-peptide antibody was used to verify above IHC results, T-antigen antibody was also used in IHC to show that micrometastsis expressed T-antigen as show in Fig [3](#F3){ref-type="fig"}B (magnification: 1000×). C. Likely, C-peptide was also expression in micrometastasis shown as Fig [3](#F3){ref-type="fig"}C (magnification: 1000×). The results suggested that micrometastasis was derived from insulinoma. D. Micrometastasis are not find in lung and spleen in C57BL/6 mice but was observed in Rip1-Tag2 mice (P\<0.0001, n=3, the number of section is 10μm/slide), shown as Fig.[3](#F3){ref-type="fig"}D. Note: micrometastassis refer to the number of tumor cell was less than 10, and advanced stage was 14 weeks.](ijbsv10p0136g003){#F3}

![**Pathological structures altering in lung and spleen in advantage stage.** A. Reactive hyperplasia of lymphoid tissue in spleen in Rip-Tag2 mice and C57BL/6 mice (background) as control. B. Thickening and bleeding of the alveolar septa, congestion of capillary, hemorrhagic foci (pink dot) was observed in lung of Rip1-Tag2 mice. Microscope magnification: 400×.](ijbsv10p0136g004){#F4}

![**Insulin and T antigen low-expression invasive carcinoma.**A. Representative image of Insulin and T-antigen IHC in Hyperplasia (left, 4 weeks) and invasive carcinoma (right, 14 weeks) (magnification: ×1000). B. The results showed insulin and T-antigen down-regulation in hyperplasia comparison with invasive carcinoma (\*\*\*P\<0.01). The mean gray level IOD/Area was used to analysis in 10 fields, the color stained brown was objective to analyze (HRP-DAB).](ijbsv10p0136g005){#F5}
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